Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses

COVID-19 mRNA vaccines protect against severe disease and hospitalization. Neutralizing antibodies (NAbs) are a first-line defense mechanism, but protective NAb responses are variable. Currently, NAb testing is not widely available. This study employed a lateral flow assay for monitoring NAb levels...

Full description

Bibliographic Details
Published in:Vaccines
Main Authors: Alexa J. Roeder, Megan A. Koehler, Paniz Jasbi, Davis McKechnie, John Vanderhoof, Baylee A. Edwards, Maria J. Gonzalez-Moa, Alim Seit-Nebi, Sergei A. Svarovsky, Douglas F. Lake
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Subjects:
mRNA vaccines
SARS-CoV-2
neutralizing antibody
lateral flow assay
Online Access:https://www.mdpi.com/2076-393X/10/9/1459

Internet

https://www.mdpi.com/2076-393X/10/9/1459

Similar Items